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ABSTRACT
$FXWHSDQFUHDWLWLV LQGXFHDFDWDEROLF VWUHVV WKDW LQFUHDVH V\VWHPLF LQÀDPPDWRU\ UHVSRQVHZLWKZRUVHQLQJ
QXWULWLRQDOVWDWXV&XUUHQWDSSURDFKLQDFXWHSDQFUHDWLWLVWKHUDS\ZDVVWLOOV\PSWRPDWLFEHFDXVHRIQRGH¿QLWLYH
WKHUDS\\HWWRSUHYHQWDQ\LQÀDPPDWRU\DQGSURWHRO\WLFFDVFDGH2QHRIWKHPRVWLPSRUWDQWWKLQJWRFRQVLGHULQ
acute pancreatitis therapy was nutritional management. “Pancreatic rest” concept that formerly used have been 
known to increase cost, sepsis incidence due to catheter use, and also metabolic and electrolyte disorder. Nowadays, 
“gut rousing” concept was preferable compared to “pancreatic rest” concept, support that nutritional management 
ZDVQHHGHGWRVWLPXODWHDQGJHQHUDWHLQWHVWLQDOIXQFWLRQ(QWHUDOQXWULWLRQDGPLQLVWUDWLRQKDYHWRFRQVLGHUSDWLHQW¶V
hemodynamic status. Necrosis incidence, respiratory failure, intensive care, and mortality was found to be lower in 
SDWLHQWVJLYHQHQWHUDOQXWULWLRQLQ¿UVWKRXUVFRPSDUHGWRDIWHUKRXUV1XWULWLRQDGPLQLVWUDWLRQYLDQDVRJDVWULF
tube or nasojejunal tube was still in doubt while several studies showed that nasogastric tube administration 
was safe and tolerated, otherwise could be evaluated in larger population sample study. Nutrition and metabolic 
monitoring was also an important part to reach nutritional goals and reduce complications. 
Keywords: acute pancreatitis, enteral nutrition, gut rousing
ABSTRAK
3DQNUHDWLWLVDNXWPHQ\HEDENDQVWUHVVNDWDEROLN\DQJPHQLPEXONDQUHVSRQLQÀDPDVLVLVWHPLNGDQSHUEXUXNDQ
status nutrisi. Pendekatan terapi pankreatitis akut saat ini masih bersifat simptomatik karena tidak ada 
WHUDSLGH¿QLWLIXQWXNPHQFHJDKDNWLYDVLNDVNDGHLQÀDPDVLGDQSURWHROLWLN6DODKVDWXKDOSHQWLQJ\DQJKDUXV
diperhatikan dalam tatalaksana pankreatitis akut yaitu pemberian nutrisi. Konsep “pancreatic rest” yang dahulu 
diterapkan saat ini diketahui meningkatkan biaya perawatan, meningkatkan kasus sepsis karena pemakaian 
NDWHWHUJDQJJXDQHOHNWUROLWGDQPHWDEROLN.RQVHSµJXWURXVLQJ¶VDDWLQLPXODLPHQJJHVHUNRQVHS³SDQFUHDWLF
rest” yaitu pemberian nutrisi diperlukan untuk menstimulasi atau membangkitkan fungsi saluran cerna. Waktu 
memulai pemberian nutrisi enteral juga harus memperhatikan hemodinamik pasien. Insidens nekrosis, gagal 
nafas, perawatan intensif, dan mortalitasnya lebih rendah pada pasien yang diberikan nutrisi enteral dalam 
48 jam dibandingkan dengan yang diberikan setelah 48 jam. Pilihan jalur nutrisi melalui selang nasogaster 
atau selang nasojejunal masih menjadi perdebatan, meskipun pada berbagai studi pemberian nutrisi melalui 
nasogastric tube (NGT) dapat ditoleransi dan aman namun diperlukan studi dengan jumlah sampel yang lebih 
besar. Monitor nutrisi dan metabolik juga bagian penting untuk mencapai target nutrisi dan mencegah komplikasi. 
Kata kunci : pankreatitis akut, nutrisi enteral, gut rousing
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INTRODUCTION
$FXWHSDQFUHDWLWLVZDVDQ LQÀDPPDWRU\GLVRUGHU
that can lead to systemic inflammatory response 
syndrome (SIRS), multiorgan failure, and death. 
Incidence in several country was various, range for 4,9-
73,4 cases per 100.000 population and still increasing 
every year. United States (US) and Finland was the 
highest prevalence country with 73 case per 100,000 
population in US and 73,4 case per 100,000 population 
in Finland. Moderate prevalence was found in New 
Zealand (29.3 case) and Norwegia (34.4 case) per 
100,000 population.1 Most of acute pancreatitis will 
UHVROYHZLWKRXWWKHUDS\RUWKHQHHGRIVSHFL¿FWKHUDS\
Among 20% of them was progressed into severe acute 
pancreatitis and need an intensive care with operative 
management. Severe pancreatitis was marked by 
sepsis, organ failure in 48 hours, or worsening clinical 
condition. This condition was caused by infected 
necrotic tissue. Intestinal bacteria translocation was 
assumed to be the main cause of infection.2
 Some definition and classification changes 
KDYHHHQPDGHVLQFH$WODQWD&ODVVL¿FDWLRQLQ
Nowadays, acute pancreatitis was divided into two 
phases: acute phase and late phase. Acute phase 
happened less than one week with main characteristic 
of sign of organ failure (SIRS). Late phase (late onset) 
occur after one week marked by local complication. 
6HYHUDO ORFDOFRPSOLFDWLRQZDVSHULSDQFUHDWLFÀXLG
pancreas or peripancreas necrosis (steril or infected), 
and pseudocyst.3 Scoring system such as APACHE 
II, Ranson, and Glasgow was an important tools to 
predict its severity. Mortality among mild pancreatitis 
was rarely found but can be as high as 40% in severe 
acute pancreatitis.2 ,Q86 D VLJQL¿FDQW LQFUHDVH LQ
acute pancreatitis case was found but its mortality rate 
was decreasing. This was caused by improvement in 
diagnosis and management of acute pancreatitis.4
Acute pancreatitis cause a catabolic stress that 
FDXVHV\VWHPLFLQÀDPPDWRU\UHVSRQVHZLWKZRUVHQLQJ
nutritional status.5 Until 1990, total parenteral nutrition 
and resting intestinal function was recommended 
in acute pancreatitis management due to reduce 
pancreatic exocrine secretion. Several studies and 
clinical experience showed that by resting pancreas 
in too long period will lead to mucosal atrophy and 
increase bacterial translocation risk so that it could 
made acute pancreatitis worse.6 Acute pancreatitis 
approach currently symptomatic because of no 
GH¿QLWLYH WKHUDS\ \HW WR UHGXFH LQÀDPPDWRU\ DQG
proteolytic cascade. Nutrition was an important part of 
acute pancreatitis management where enteral nutrition 
was more recommended than total parenteral nutrition.1 
This article will review about nutritional management 
in acute pancreatitis. Only some studies that investigate 
mild and moderate acute pancreatitis, so that this 
review will discuss about acute pancreatitis in general.
ACUTE PANCREATITIS PATHOPHYSIOLOGY
Digestion and absorption was a complex process 
that need coordination of several secretion function 
from gastrointestinal organ, motoric function, and also 
circulatory system. Pancreas plays an important role 
in this physiology. Acute pancreatitis characterized 
by severe pain mainly in upper abdomen area with 
increasing pancreatic enzyme level in serum. Acute 
pancreatitis started from acinar cell disorder. Several 
mechanism underlie pancreatic acinar cell disorder7:
1. Pancreatic duct obstruction by stone, bile, or Oddi 
sphincter spasm (e.g. caused by alcoholism).
2. Cholecystokinin hormone stimulation that activate 
pancreatic enzymes. This hormone was stimulated 
by high fat and protein diet. 
3. Transient ischemia caused by operatif procedure 
or atherosclerosis. This condition will lead to 
pancreatic enzyme degradation. 
Figure 1. Digestive enzyme activation inside acinar cell
Several mechanism underlie zymogen conversion 
in pancreas into its active form, such as autoactivation 
of trypsin from trypsinogen by lysosomal hydrolase 
cathepsin B (CTSB), zymogen and lysosome leakage 
to cytoplasm and activation. This acinar cell disorder 
followed by pancreatic enzyme release to pancreatic 
tissue. Trypsinogen, chemotrypsin, and elastase in acinar 
cell will spontaneously activated and furthermore cause 
autodigestion. Trypsin will also activate complement 
V\VWHPFRDJXODWLRQDQG¿EULQRO\VLVSURFHVV(QGRWKHOLDO
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dysfunction would lead to increase vascular permeability 
that trigger proinflammatory cytokines production 
(IL-1,6,8, TNFĮIUHHUDGLFDODQGDUDFKLGRQDWHDFLG
metabolite (prostaglandin, platelet activating factor, 
leukotriene) and proteolytic enzyme which induce 
thrombosis and tissue hemorrhage.7
In mild and moderate acute pancreatitis, the 
necroting segment was stil sterile. Ischemic and 
necrotic condition will be worsen by bacterial 
translocation from intestinal via lamina propria, 
mesenteric lymphnodes, and than into systemic 
circulation that cause infected necrosis. Bacterial 
translocation was caused by increase intestinal 
permeability that could be measured by increase 
polyethylene glycol (PEG) excretion in urine and 
antiendotoxin antibody (Endocab). IL-6 concentration 
reach its highest concentration in 36 hours after the 
onset of pain and organ dysfunction was found in the 
third day, so that ‘therapeutic window’ was between 
48 to 72 hours after the onset of pain.7
Immune dysregulation was one of the factors that 
increase mortality in acute pancreatitis and also played 
an important role in SIRS and multiorgan failure 
incidence. Sel Th1 and Th 2 imbalance were the main 
mechanism of immune dysregulation. Th1 cell release 
DQWLLQÀDPPDWRU\IDFWRUVVXFKDV,/DQG,/ZKLOH
7KUHOHDVHSURLQÀDPPDWRU\IDFWRUVVXFKDV,/DQG
TNF-alpha. A study by Pietruczuk showed that in acute 
phase, Th1 cell was suppressed so that the more active 
7KZLOOWULJJHUSURIRXQGLQÀDPPDWRU\UHVSRQVH8
In acute pancreatitis with sepsis, 80% among 
patients was in hypermetabolic condition. Nutritional 
requirement was increase because of increase resting 
energy espenditure (REE) and protein breakdown. 
Negative nitrogen balance was also impact patient 
prognosis. In acute pancreatitis, nitrogen loss was 
approximately 20-40 gram each day. Several amino 
DFLG GH¿FLHQF\ZLOOZRUVHQ LQÀDPPDWLRQ SURFHVV
The increasing endogen gluconeogenesis was a severe 
LQÀDPPDWLRQPDQLIHVWDWLRQ,QSDWLHQWZLWKVHSVLVDQG
trauma, endogenous gluconeogenesis could only be 
suppressed partially by exogenous glucose. Oxygen 
consumption increase by 20-30% cause the need of 
more energy supply or reduce perfusion to several vital 
organs. Both was caused by hypovolemia and reduce 
FDUGLDFIXQFWLRQEHFDXVHRILQÀDPPDWLRQSURFHVV8
In acute pancreatitis, capillary permeability will 
increase and lead to pancreatic enzyme leakage. This 
will trigger local hydrolysis process of triglyceride 
that comes from cylomicrone. This hydrolysis process 
was toxic and induce further pancreatic destruction. 
An animal study showed that triglyceride cause 
pancreatitis and increase serum free fatty acid. This 
will lead to microthrombus formation that cause tissue 
ischemia.9 Negative nitrogen balance was correlate to 
worse prognosis in severe acute pancreatitis. Pancreas 
also need amino acid for its protein synthesis program.9
Carbohydrate was the main source of energy in 
acute pancreatitis because of its wide availability, 
its ability to suppress intrinsic gluconeogenesis, and 
reduce hyperlipidemia risk. A maximum of 4 mg/
kgBW/minute of glucose can be given with always 
monitor hyperglycemia and hypercapneu risk. Insulin 
secretion was also impaired in acute pancreatitis so 
that parenteral nutrition administration will increase 
hyperglycemia risk. Insulin resistance could only be 
corrected by exogenoud insulin administration.9 
Table 1. Nutritional requirement in acute pancreatitis 
Total calorie NFDONJ%:GD\
Carbohydrate Less than 5 mg/kgBW/minute
Fat /HVVWKDQJUDPNJ%:GD\
Protein JUDPNJ%:GD\
9LWDPLQWUDFHHOHPHQW 9LWDPLQ$&(DQGVHOHQLXP
KgBW: kilogram of body weight
ENTERAL NUTRIT ION ROLE IN  ACUTE 
PANCREATITIS 
There were no specific therapy yet for acute 
pancreatitis, but in general an early treatment will 
improve patient outcome. Fluid resuscitation, analgesic 
drugs, and antibiotic prophylaxis was the main treatment 
for acute pancreatitis. However, lower mortality seen 
in last decade was known to be affected by nutritional 
management. Enteral nutrition was improved to be the 
part of acute pancreatitis management.4
Table 2. Enteral nutrition guideline for severe acute pancreatitis 
management6
Association Recomendation
International 
Concensus 
Comittee
In general, enteral nutrition was chosen 
rather than parenteral nutrition, or at least 
being prioritized. Enteral nutrition that used 
was peptide and medium-chain triglyceride 
basis. 
European Society 
for Clinical Nutrition 
and Metabolism 
(ESPEN)
In necrotican pancreatitis, enteral nutrition 
was given if possible. Amount was formulized 
based on safety peptide quantity. Standard 
nutrition could be given if tolerated. 
American Society 
for Parenteral and 
Enteral Nutrition 
(ASPEN)
Patient with severe acute pancreatitis could 
be given enteral nutrition with gastric or 
jejunal route. Tolerantion could be increased 
by changing intact protein into small protein 
and long-chain fatty acid into medium-chain 
triglycerides. 
American college of 
gastroenterology
In acute pancreatitis, enteral nutrition was 
recommended to prevent infection as 
complication. Parenteral nutrition should 
be avoided except enteral nutrition was 
unavailable, untolerated, or nutritional 
UHTXLUHPHQWLVQRWIXO¿OOHG
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The importance of nutrition role in acute pancreatitis 
has been known since 70’s era. Parenteral nutrition was 
a standard therapy for the last four decades based on 
‘pancreatic rest’ concept. ‘Pancreatic rest’ concept 
told that nutrition administration above mid jejunum 
will stimulate pancreatic enzyme. According to this, 
per oral nutrition was started since acute pancreatitis 
sign reduced so that pancreatic enzyme will turn back 
to its normal level.4 
The rationality of this ‘pancreatic rest’ concept is 
WKDW E\ UHVWLQJ LQÀDPHG SDQFUHDV LWZLOO VWLPXODWH
proteolytic enzyme release and reduce exocrine 
stimulation. Otherwise, this pancreatic enzyme 
secretion was known to be inverse with pancreatitis 
severity. Patients with severe acute pancreatitis will 
secrete lower level of trypsin, amylase, and lipase than 
mild to moderate acute pancreatitis patients because 
RILWVLQVXI¿FLHQF\,QVXI¿FLHQF\VHYHULW\ZDVEDVHG
on disease severity. Unfunctional acinar cell could not 
respond to physiologic secretion stimulus.10 
This ‘pancreatic rest’ concept was correlate to 
higher administration cost, increase sepsis risk because 
of catheter used, and increase risk of electrolyte and 
metabolic disorder. Several studies also showed that 
it also caused gastrointestinal barrier dysfunction 
and increased permeability. Parenteral nutrition was 
also induce electrolyte imbalance, hyperglycemia, 
intestinal barrier dysfunction, and increase intestinal 
permeability so that ‘pancreatic rest’ was doubt.4
Enteral nutrition was having an immunomodulatory 
effect for systemic and intestinal mucosa. Intestinal 
epithelial cell integrity and immune cell along 
lymphoid tissue together with intestinal barrier 
played an important role in homeostasis and bacterial 
translocation. Intestinal epithelial cell was not only 
functioned as intestina mucosal defence, but also to 
support lymphocyte cell function and maturation. 
Intestinal mucosa permeability was the main parameter. 
Immunoglobulin M was an indirect marker for 
intestinal permeability. Three RCT shown an IgM 
reduction in patients received enteral nutrition.4,11
Nowadays, ‘gut rousing’ concept was slowly 
replace ‘pancreatic rest’. It explained that nutrition 
administration was needed to stimulate and generate 
ĂĐƵƚĞ ƉĂŶĐƌĞĂƚŝƚŝƐ
WĂƚŚŽŐĞŶĞƚŝĐ ĨĂĐƚŽƌƐ
EŽƌŵĂů ŝŶƚĞƐƚŝŶĂů
ĨƵŶĐƚŝŽŶ
/ŶƚĞƐƚŝŶĂů
ĚǇƐĨƵŶĐƚŝŽŶ
EŽŶͲŽƉŝĂƚĞ ĂŶĂůŐĞƐŝĐ
&ůƵŝĚ ƌĞƐƚƌŝĐƚŝŽŶ
KƉŝĂƚĞ ĂŶĂůŐĞƐŝĐ
EŽƌŵĂů ŝŶƚĞƐƚŝŶĂů
ĨƵŶĐƚŝŽŶ
/ŶƚĞƐƚŝŶĂů
ĚǇƐĨƵŶĐƚŝŽŶ
/ŶƚĞƐƚŝŶĂů
ĚǇƐĨƵŶĐƚŝŽŶ
EŽƌŵĂů ŝŶƚĞƐƚŝŶĂů
ĨƵŶĐƚŝŽŶ
ZĞĐŽǀĞƌǇ ƉŚĂƐĞ WĂŶĐƌĞĂƚŝƚŝƐ ƐĞǀĞƌŝƚǇ
ƉƌŽŐƌĞƐƐŝǀŝƚǇ
Figure 2. ‘Gut rousing’ concept, four phases of nutritional management in acute pancreatitis1
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intestinal function, contrastly differ to ‘pancreatic 
rest’ concept. In ‘gut rousing’ concept, there were 
four important phase: (1) Phase I: from onset of 
acute pancreatitis until hospital administration; (2) 
Phase II: from hospital administration until 24 hours 
DIWHUÀXLGUHVXVFLWDWLRQ3KDVH,,,¿QDOSKDVHRI
UHVXVFLWDWLRQ WR IXO¿OOHG FDORULH QHHGV KRXUV
after resuscitation end); (4) Phase IV: after phase III 
until recovery stage.
There were several factors that affect intestinal 
function and patients outcome in each phase. 
Acute pancreatitis was started from local pancreas 
LQÀDPPDWLRQ VR WKDW LQ 3KDVH , LQWHVWLQDO IXQFWLRQ
is normal. But, not all patients was having normal 
intestinal function so that therapy in the next phase 
will have an impact on the later phases. In phase II, 
ÀXLG UHVXVFLWDWLRQ DQGSDLQPDQDJHPHQWZDV GRQH
Resuscitation in acute pancreatitis should be done 
aggressively with positive balance, but this increased 
risk of intestinal submucosal edema and ileus. Opiate as 
analgesic have a side effect to delay gastric emptying, 
inhibit gastric motility, reduce pancreatic enzyme 
secretion and intestinal hormone so that intestinal 
dysfunction was mainly caused by iatrogenic etiology. 
Strategies to reduce this effect was giving per oral 
nutrition in normal intestinal patients and nasogastric 
tube for patients with intestinal dysfunction. If there 
were no enteral nutrition administration during phase 
III, it will worsen intestinal dysfunction and cause 
a progressive acute pancreatitis. In this phase, per 
oral nutrition should be consider, or using tube. This 
nutritional optimalization in this phase III will affect 
patient prognosis.10
Meta-analysis done by McClave, Marik, and 
Zalogan showed that enteral nutrition will reduce 
infection complication, length of stay, and organ-
failure risk. However, enteral nutrition in this studies 
did not reduce mortality. Meta-analysis by Petrov et 
al involving 202 severe acute pancreatitis patients 
showed significant mortality difference of 4% 
compared to 15,9%. A study by Cao et al showed 
a reduced mortality and organ failure incidence 
among enteral nutrition intervention group while a 
metaanalysis by Yi et al showed a reduced mortality, 
infection complication, and surgical intervention, but 
QRVLJQL¿FDQWGLIIHUHQFHLQOHQJWKRIVWD\,QFOLQLFDO
VWLQJV WKHUHZHUH QR VSHFL¿F FRQWUDLQGLFDWLRQ IRU
enteral nutrition administration. This could still be 
DGPLQLVWHUHGDOWKRXJKD¿VWXODDVFLWHVRUSVHXGRF\VW
present, except in severe ileus.12
ENTERAL NUTRITION ADIMINSTRATION TIME
During pancreatitis, intestinal dysfuction will 
LQFUHDVH LQÀDPPDWRU\ UHVSRQVH DQG RUJDQ IDLOXUH
risk. In multicenter study, Besselink et al showed 
WKDWEDFWHUHPLDZDVKDSSHQHGLQWKH¿UVWVHYHQGD\V
Bacterial translocation will triger SIRS and could 
lead to sepsis. Early enteral nutrition administration 
could improve intestinal barrier and prevent bacterial 
translocation.12
Unstable hemodynamic level cause intestinal 
ischemia so that enteral nutrition in this phase 
will worsen ischemia and could lead to necrosis 
and bacterial overgrowth. Fluid resuscitation was 
QHHGHGWR¿OOGHSOHWHGLQWUDYDVFXODUÀXLGDQGUHGXFH
splanchnic vasoconstriction reflex before enteral 
nutrition administration. Therefore, enteral nutrition 
was recommended no to be given too early until 
SKDVH ,,, H[DFWO\ DIWHU ÀXLG UHVXVFLWDWLRQ (QWHUDO
nutrition could be administered 24-48 hours after stable 
hemodynamic and intestinal function, and expected to 
IXO¿OOQXWULWLRQDOWDUJHWLQKRXUV
Absolute enteral nutrition contraindication was 
multiple trauma with peritonitis ann retroperitoneal 
hematoma, intestinal obstrukction, active intestinal 
bleeding, and unstable hemodynamic level. Relative 
contraindication where parenteral nutrition was still 
QHHGHGLVGLYHUWLFOHDEFHVVPDODEVRUSWLRQ¿VWXODEDG
tolerance, and malnutrition.11
A metaanalysis by Petrov et al that reviwed 11 RCT 
showed a reduction in organ failure risk, infection 
complication, and mortality in patients given enteral 
QXWULWLRQ LQ WKH¿UVW  KRXUV ,I HQWHUDQO QXWULWLRQ
DGPLQLVWHUHGDIWHUKRXUVWKHUHZHUHQRVLJQL¿FDQW
differences. An RCT study by Sun et al investigate 
Table 3. Studies that compared enteral and parenteral nutrition12
Reference Year &RXQWU\,QVWLWXWLRQ Sample Size Control 
%HQH¿WRIHQWHUDOFRPSDUHGWR
parenteral nutrition 
Paraskeva et al  Yunani/Pireus General Hospital 23 Parenteral nutrition Lower surgical intervention 
Olah et al  Hungaria/Petz A. Teaching Hospital,  Parenteral nutrition Lower sepsis complication
Abou-assi et al  $PHULNDVHULNDW9LUJLQLD8QLY+RVS 53 Parenteral nutrition Lower sepsis complication, lower cost
Gupta et al  Inggris/Southampton General Hospital  Parenteral nutrition Shorter length of stay, lower cost
Louie et al  Kanada/University of Alberta 28 Parenteral nutrition Lower complication and better glycemic 
control
Eckerwall et al  Swedia/Lund University Hospital  Parenteral nutrition Lower mortality and organ failure
Petrov et al  Russia/Nizhny Novgorod Hosp 22 Parenteral nutrition 1RVLJQL¿FDQFHLQPRUWDOLW\
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enteral nutrition administration in 48 hours and its 
relation to immune function and outcomes in 60 severe 
acute pancreatitis patients. Patiens received enteral 
QXWULWLRQ LQ¿UVW  KRXUV VKRZHG D ORZHUPXOWLSOH
organ failure syndrome, SIRS, and pancreatic infection 
compared to patients received enteral nutrition after 
day-8. Otherwise, mortality among both group was 
not signiciantly difference.12
Wereszczynska-Siemiatkowska et al investigate 
197 patients with severe acute pancreatitis, result in 
lower necrosis incidence, respiratory failure, intensive 
care, and mortality among patients received enteral 
QXWULWLRQLQ¿UVWKRXUVFRPSDUHGWRDIWHUKRXUV
Surgical intervention and multi organ failure was also 
found to be lower. Enteral nutrition in this study was 
using nasojejunal route. All death subject (9 patients) 
was from group that received enteral nutrition after 48 
hours. There were no difference in local complication 
among both groups. Infection complication predictor 
was SIRS > 48 hours, enteral nutrition > 48 hours, and 
APACHE score in day-3.12
In mild acute pancreatitis, enteral nutrition could be 
DGPLQLVWHUHGHDUO\ZLWKRXWDQ\VSHFL¿FLQWHUYHQWLRQ
Study by Eckerwall et al that randomized 50 acute 
SDQFUHDWLWLVSDWLHQWVWRFRPSDUHWKHHI¿FDF\DQGVDIHW\
of enteral nutrition in 24 hours to total parenteral 
nutrition. Enteral nutrition was given via nasogastric 
route. There were no difference in amilase level and 
SIRS between both group, but hyperglycemia was 
found to be lower in enteral nutrition group. Nutrition 
should not always be started from liquid diet, but it 
LVPRUHVDIHWRJLYHORZIDWVRIW¿HW(DUO\QXWULWLRQDO
intervention will reduce length of stay.8
OPTIMAL ROUTE FOR ENTERAL NUTRITION
There were still in debate which location is the 
best for enteral nutrition administration. There are 
two options: postpyloric, especially jejenum, and 
prepyloric in stomach. Postpyloric tube insertion needs 
endoscopy specialist or radiologist, and this could lead 
to late eneteral nutrition administration.4
Tube insertion in jejenum was correlate to 
‘pancreatic rest’ concept. Based on that concept, 
nutritional administration in upper GI tract (above 
jejenum) will stimulate pancreatic enzyme secretion 
that worsen patients condition, so that gastric tube 
insertion was avoided. Nasogastric tube considered to 
increase aspiration and pancreas stimulation risk. This 
opinion have been investigated in several studies. 4
Several RCT and meta analysis showed that 
nutritional administration via nasogastric route and 
nasojejunal route have a better safety and tolerantion in 
critical patients. Acute pancreatitis patients tend to have 
LOHXVFDXVHGE\LQÀDPHGSDQFUHDV7KLVDOVRVXSSRUW
the evidence that jejunal nutritional administration 
was better.4
Meta analysis that compare nasogastric and 
nasojejunal route was reviewing three RCT. In that 
VWXG\WKHUHZHUHLQVLJQL¿FDQWGLIIHUHQFHLQPRUWDOLW\
(RR = 0.69; 95% CI: 0.37-1.29; p = 0.25), aspiration 
(RR = 0.46; 95% CI: 0.14-1.53, p = 0.20), diarhea (RR 
= 1.43; 95% CI: 0.59-3.45; p = 0.43), exacerbation of 
pain (RR = 0.94; 95% CI: 0.32-2.70; p = 0.90) and 
QXWULWLRQDOVXI¿FLHQF\55 &,
p = 0.97) among both groups. In general, patients 
WROHUDQWLRQIURPERWKJURXSZDVQRWVLJQL¿FDQWO\GLIIHU
and no aspiration incidence in both group. RCT that 
included were consistenly found no difference in safety 
and tolerantion of both group. 13 A study by Kumar et al 
showed a higher mortality rate in both group because 
of late nutritional administration in conservative acute 
pancreatitis treatment will increase mortality rate.11
Eatock et al investigate the use of gastric tube 
for severe acute pancreatitis patients, followed by 
two another RCT, concluded that enteral nutrition 
administration via nasogastric tube (NGT) was well-
WROHUDWHG DQG QR VLJQL¿FDQW GLIIHUHQFH LQPRUWDOLW\
and the need of surgical correction. Two meta analysis 
with 131 severe acute pancreatitis concluded that there 
were no difference in motality, length of stay, infection 
complication, and multi organ failure in patients 
having nutrition via nasogastric tube and conventional 
method. However, there were still need a larger sample 
size study for the effectivity of NGT nutritional route 
tolerantion and safety.12
7DEOH6WXGLHVLQYHVWLJDWHWKHEHQH¿WRIHQWHUDOQXWULWLRQDW¿UVWKRXUVYVDIWHUKRXUV12
Study Year &RXQWU\LQVWLWXWLRQ Sample size Control 
%HQH¿WRIHDUO\KRXUVHQWHUDO
nutrition 
Sun et al  Cina/ Nanjing Medical
University
 Enteral nutrition in day-8 Lower SIRS, organ failure, and complication
W e r e s z c y n s k a -
Siemiat kowska et al
 Polandia/ Medical 
University Bialystok
 (QWHUDOQXWULWLRQDIWHU!KRXUV Lower mortality and complication
Sun et al  China/Nanjing Medical 
University
 Enteral nutrition in day-8 Lower intraabdominal hypertension
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From several study above, nasogastric tube location 
was not stimulating pancreas but less known about its 
effect on pancreatic secretion stimulation. A developed 
hypothesis told that nasogastric tube will stimulate 
SDQFUHDWLFHQ]\PHEXWFOLQLFDOO\LQVLJQL¿FDQW14 This 
was investigated by O’keefe et al. Per oral liquid 
polymeric diet compared to placebo showed an 
LQFUHDVH DPLODVH WU\SVLQ DQG OLSDVH VLJQL¿FDQWO\
Polymeric enteral formula administration into 
duodenum also stimulate amilase, trypsin, and lipase, 
otherwise elemental formula only slightly increase 
lipase. Studies also compared secretory response in 
nutritional administration at duodenum, mid-jejunal 
(40-60 cm distal ligamentum treitz) and distal jejunum 
(100-120 cm distal ligamentum treitz). There were 
QRVLJQL¿FDQWGLIIHUHQFHDPRQJWKRVHWKUHHGLIIHUHQW
locations. Low trypsin and lipase secretion were found 
in elemental formula administration in mid jejenum. 
This response was similar to control group (fasting). 4
7KHEHQH¿W RI QDVRJDVWULF WXEHZDV QRW RQO\ LQ
severe acute pancreatitis, but also in mild and moderate 
acute pancreatitis.5 Per oral nutritional administration 
via nasogastric route still stimulate pancreas but its 
effect was subclinical and did not affect outcomes.1 
Mild to moderate acute pacreatitis early nasogastric 
tube feeding compared with pancreatic rest (MIMOSA) 
was a study that firstly investigate the safety, 
WROHUDQWLRQDQGHI¿FDF\RIQXWULWLRQDODGPLQLVWUDWLRQ
via nasogastric tube in non-severe acute pancreatitis 
patients. Approximately in 30%, SIRS was found in 
the early hospital admission with median APACHE 
score of 6 in both group. This study compared enteral 
QXWULWLRQYLDQDVRJDVWULF WXEH LQ¿UVW KRXUV DIWHU
hospital admission to non enteral feeding patients. The 
result showed that patients given enteral nutrition was 
not having progressive pancreatitis. This study was 
also showed that enteral nutrition reduce intensity and 
duration of abdominal pain, reduce opiate-analgesic 
needs, and reduce intolerantion risk.14 From several 
studies, ‘pancreatic rest’ have not been proven to 
improce acute pancreatitis patients and now ‘gut 
rousing’ concept was used as an important part of acute 
pancreatitis management. 15
ENTERAL NUTRITION FORMULA
In acute pancreatitis nutrition management, besides 
tube location, nutritional formula was also an important 
thing. Several composition could increase pancreatic 
secretion response so that in ‘pancreatic rest’ concept, 
nutritional formula was very important. There were 
PRUHWKDQYDULHW\RIIRUPXODPDLQO\FODVVL¿HGLQWR
three types: (1) Elemental, composed of amino acid or 
oligopeptide, maltodextrin, and medium-chain or long-
Table 5. Studies of nasogastric tubes for acute pancreatitis patients12,13
Study Country Method Control group Average APACHE VFRUH1*71-
Time of 
administrartion
Nutrition 
formula Duration
(DWRNHWDO UK RCT Nasojejunal  KRXUV Semielemental 5 days
.XPDUHWDO India RCT Nasojejunal  KRXUV Semielemantal 7 days
(FNHUZDOOHWDO Sweden RCT Parenteral  KRXUV Polymeric GD\V
6LQJKHWDO  India  RCT  Nasojejunal 8,5/8 KRXUV  Semielemental  7 days
NGT: nasogastric tube; NJ: nasojejunal
Table 6. Safety and tolarention of nasogastric tube12,13
Study Sample size Diarhea (%)1*71-
Pain after nutritional 
administration (%) 
1*71-
Aspiration (%)
1*71-
1XWULWLRQDOVXI¿FLHQF\
1*71-
(DWRNHWDO 27   78% /77,2%
$IWHUKRXUV
.XPDUHWDO     DIWHUGD\V
(FNHUZDOOHWDO 23  - 66% after 7 days
6LQJKHWDO     
After 7 days
Total    N/A
NGT: nasogastric tube; NJ: nasojejunal
Table 7. Outcome pancreatitis patients with nasogastric tubes12,13
Study Ventilator(%) 
MODS
(%)
Infected necrosis
 (%)
Operation
(%)
Mortality 
(%)
Length of stay 
(day)
(DWRNHWDO  - - -  
.XPDUHWDO    6,3%  
(FNHUZDOOHWDO 8,7%     
6LQJKHWDO 66,7% 28,2%    
Total      N/A
MODS: multiple organ disfunction syndrome
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chain triglyceride; (2) Polymeric, composed of non-
hydrolized protein, maltodextrin, oligofructosacharide, 
and long-chain triglyceride; (3) Immune enhancing, 
composed of substrate that enhance immune activity 
such as glutamine, arginine, and omega-3 fatty acid, 
SURELRWLFDQG¿EHUULFKIRUPXOD
In acute pancreatitis patients, elemental nutrition 
VKRZHG VHYHUDO EHQH¿W FRPSDUHG WR SRO\PHULF LQ
absorption, less stimulating pancreas, and highet 
tolerantion. Otherwise, this elemental nutrition was 
high cost. Elemental nutrition and immune enhancing 
formula have a higher osmolarity than polymeric 
formula, so that it could cause diarrhea. 10 Nutritional 
composition could increase tolerantion and patients 
compliance. Patients with severe acute pancreatitis 
were recommended to received peptide and medium-
chain triglyceride formula. Medium-chain triglyceride 
ZDVNQRZQWRKDYHDQWLLQÀDPPDWRU\HIIHFWEXW LWV
evidence was limited to animal studies.6
High-fiber formula with prebiotic vs igh-fiber 
formula
Microbiota inside intestinal lumen have an important 
role in infection at acute pancreatitis. In peripancreatic 
ÀXLGDQDO\VLVEDFWHULDWKDWFDXVHLQIHFWLRQZDVNQRZQ
to come from intestinal. Therefore, improving intestinal 
bacteria balance was one of the management target 
that now being studied. In previous study, probiotic 
has a lowering effect of CRP level and also APACHE 
II score.6 But, a study by Besselink et al doubt the 
effects of prebiotic. Besselink randomized 298 patients 
predicted as severe acute pancreatitis into two groups. 
Intervention group received probiotic, compared to 
placebo group. Infection complication in both group 
ZDVQWVLJQL¿FDQWO\GLIIHUHQW0RUWDOLW\ZDVIRXQGWR
be higher in intervention group.9
0HWDDQDO\VLVIURP5&7FRPSDULQJKLJK¿EHU
diet with no-fiber diet showed a reduce diarrhea 
LQFLGHQFH7KLV VWXG\ H[SODLQHG WKDW ¿EHU FRXOG EH
considered clinically to reduce diarrhea.11 This enteral 
IRUPXODZDVVLJQL¿FDQWO\UHGXFHVHSVLVFRPSOLFDWLRQ
but not in mortality of both group.10 Several studies 
VKRZHG WKDW WKHUHZHUH QR VLJQL¿FDQW GLIIHUHQW LQ
tolerantion, infection complication risk, and mortality 
between polymeric and enteric formula nutrition. High-
¿EHUGLHWZDVDOVRVDIHEXWDGGLQJLPPXQRQXWULHQRU
probiotic did not improve patients outcome.
Propratria trial showed that probiotic administration 
in severe acute pancreatitis patient will increase 
intestinal ischemia risk, organ failure, and mortality, 
VLJQL¿FDQWO\%XW LW VKRXOG EH QRWHG WKDW SURELRWLF
given in this study was widely variated so that high-
fiber diet combined with probiotic will increase 
mortality.15
Immunonutrien in acute pancreatitis
Meta analysis by Asrani et al involving 505 
patients from 12 studies showed that glutamine 
VXSSOHPHQWDWLRQ VLJQL¿FDQWO\ UHGXFHPRUWDOLW\ 55
= 0.30; 95%; CI: 0.15-0.60; p0.001) and infection 
complication (RR = 0.58; 95% CI: 0.39-0.87; p = 
EXWGLGQRWUHGXFHOHQJWKRIVWD\7KHEHQH¿W
of glutamine supplementation was clearly found in 
enteral nutrition. Enteral nutrition supplemented by 
intravenous glutamine will reduce pancreatic necrosis, 
infection complication, and length of stay.12
PARENTERAL NUTRITION IN ACUTE PANCREATITIS 
Based on ESPEN recommendation, parenteral 
nutrition indication in acute pancreatitis was inadequacy 
of enteral nutrition after 5-7 days. This period could be 
shorter in formerly malnourished patients. Complication 
VXFKDVLOHXVSVHXGRF\VWSDQFUHDWLF¿VWXODLQWHVWLQDO
edema, pancreatic ascites, and infected necrosis impair 
enteral nutrition administration so that those patients 
was recommended to received parenteral nutrition. 
There were no absolute contraindication for parenteral 
nutrition. Parenteral nutrition could be started in 24-48 
hours after resuscitation and stable hemodynamics.14 
In mild acute pancreatitis study, partenteral nutrition 
for 5-7 days have no positive effect so that it is not 
recommended, except in malnourished patients. 
Substrate metabolism in severe acute pancreatitis was 
similar to severe sepsis patients. Daily nitrogen target 
was 0,2-0,24 gram/kgBW. This target was similar to 
amino acid administration of 1,2-1,5 gram/kgBW/
day. A reduction of 0,14-0,2 gram nitrogen/kgBW/day 
should be done in patients with chronic kidney disease 
or liver disease.16
Glutamine was an amino acid that have a central 
role in metabolism process such as nitrogen transport 
between organs, anabolize carbons, nucleotide and 
glutation precursor, and acid base regulator. An RCT 
study in moderate acute pancreatitis explained that 
parenteral nutrition with glutamine reduce overall 
complication and also reduce length of stay. There 
were no data for other amino acid administration in 
acute pancreatitis patients, such as BCAA, EAA, and 
arginine.14
Glucose should fulfill 50-70% of total calorie 
needs. Glucose was also prevent gluconeogenesis, 
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but hyperglycemia as side effect should be prevented. 
In acute pancreatitis and other critical condition, 
glucose oxidation reach its maximum level, about 4-7 
mg/kgBW/minute, similar to 5-6 gram/kgBW/day. if 
glucose consumption higher than this limit, lipogenesis, 
hypercapneu, and hyperglycemia will happen. This risk 
was increasing in severe acute pancreatitis because of 
SDQFUHDWLFQHFURVLVDQGLQÀDPPDWLRQUHGXFHLQVXOLQ
secretion. Data of non-carbohydrate glucose in acute 
pancreatitis patients was very limited.1
OR TOLERANTION AND NUTRITIONAL ADEQUACY 
Nutritional and metabolic monitor was aimed 
to control macronutrien (glucose, protein, fat) and 
micronutrient level, evaluate energy, and control 
glycemia. Macronutrien was evaluated intensively 
in 48 hours. In acute phase, blood glucose lecel 
was evaluated several time in a day, and reduce to 
once a day after acute phase. Electrolyte, ureum, 
creatinine, phosphate, magnesium, and liver function 
Not well-tolerated or inadequate calorie
intake in 3-5 days
Well-tolerated: no pain, no
abdominal distension
Pancreatitis severity assessment:
mild or moderate
Start enteral nutrition in 24
Increase diet progressively,
evaluate tolerantion
Combine with
parenteral nutrition
Normal diet in 5-7 days
Acute pancreatitis severity
assessment
Stable hemodynamic
Continuous enteral nutrition via tube for
24-48 hours, elemental diet
Enteral nutrition contraindication,
severe ileus
Total parenteral nutrition or
continuous enteral nutrition in
small amount (10-30 ml/hours)
Nutritional
requirement
insufficient for 3 days
Combine with
parenteral
nutrition
monitor tolerantion,
triglyceride, and glucose
Stop parenteral
nutrition if triglyceride
> 12 umol/L
well-tolerated: continue
enteral nutrition
Well-tolerated,
nutrition requirement
fulfilled
Continue enteral
nutrition feeding
Figure 3. Nutritional management of mild to moderate acute pancreatitis
Figure 4. Nutritional management in severe acute pancreatitis
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were monitor before nutritional administration. If 
abnormalities found, daily evaluation was done until 
normal, then continued to several times in a week. 
Albumin was not evaluated in acute phase but every 
week in post acute and rehabilitation phase. Body 
weight and muscle mass were evaluated in post acute 
and rehabilitation phase. 16
CONCLUSION
Acute pancreatitis management was aimed to support 
hemodynamic and prevent infection complication. 
Patients with acute pancreatitis was susceptible to 
be malnourished because of lower intake and higher 
catabolism processs so that nutritional management was 
YHU\LPSRUWDQWHVSHFLDO\WRIXO¿OOQXWULWLRQDOUHTXLUHPHQW
and modulate immunity. ‘Pancreatic rest’ concept’ was 
now slowly replaced by ‘gut rousing’ concept. Enteral 
nutrition was chosen rather than parenteral nutrition 
or fasting because it lower length of stay, infection 
complication risk, and have a lower budget. Parenteral 
nutrition was still be used if nutritional intake was 
inadequate during 3-5 days or therapy, or in the condition 
of enteral nutrition contraindicated. Otherwise, otatl 
parenteral nutrition will increase infection risk, 
metabolic complication, electrolyte disturbance, 
KLJKHUFRVWDQGKLJKHUPRUWDOLW\ULVNLQJHQHUDO)XO¿OO
nutritional requirement and prevent pancreas exocrine 
stimulation should not alter the main goal of therapu to 
increase intestinal function.
In mild acute pancreatitis, enteral nutrition could 
be administered as soon as possible since there were 
no contraindication. Nutritional administration via 
nasogastric tube was better than nasojejunal, and 
proven not to worsen pancreatitis condition. Parenteral 
nutrition should be acouded except enteral nutrition 
FRXOGQRWIXO¿OOGDLO\FDORULHUHTXLUHPHQW1XWULWLRQDO
and metabolic nutrition should be done regularly 
to control macronutrien (glucose, protein, fat) and 
micronutrient, evaluate total energy, control glycemia 
and hypertriglyceride.
REFERENCES
1. Sun E, Tharakan M, Kapoor S. Poor compliance with ACG 
guideline for nutrition and antibiotics in the management of 
acute pankreatitis: a North American survey of gastrointestinal 
specialists and primary care physicians. J Pancreas 
2013;14:221-7.
2. Ahmad AS, Iain JD, Mc CB, Peter E, Coyne A, Keith S. 
Nutritional strategies in severe acute pankreatitis: a systematic 
review of the evidence. The surgeon 2010;8:105–10.
3. Tenner S, Baillie J, De WJ. American collage of 
gastroenterology guideline: management of acute pancreatitis. 
Am J Gastroenterol 2013;108:1400-15.
4. 3HWURY01XWULWLRQ ,QÀDPPDWLRQ DQG DFXWH SDQNUHDWLWLV
,651,QÀDPPDWLRQ
5. Uomo G. Pancreatic rest or not? The debate on the nutrition in 
acute pankreatitis outcome. Journal of the Pancreas 2013;14(2)
6. Refaat A Hegazi, Tiffany DeWitt. Enteral nutrition and immune 
modulation of acutepankreatitis. World J Gastroenterol 
2014;20:16101-5.
7. Feldman M, Feldman L, Brand L. Gastrointestinal and liver 
disease ninth edition volume 1. Elsevier 2010
8. Sun JK, Mu XW, Li W. Effect of early enteral nutrition on 
immune function of severe acute pankreatitis patient. World 
J Gastroenterol 2013;19:917-22.
9. Petrov M. Moving beyond the ‘pancreatic rest’ ini severe and 
critical acute pancreatitis. Petrov Critical Care. 2013;17:161-5.
7DEOH0RQLWRULQJSDUHQWHUDODQGHQWHUDOQXWULWLRQLQVHYHUHDFXWHSDQFUHDWLWLV17
Criteria Aim Method Period 
Energy target 3UHYHQWHQHUJ\GH¿FLW Calculation of energy 
expenditure with indirect 
calorimeter
,QKRXUVDWSDVWDFXWHDQG
rehabilitation phase
Protein and fat target 3UHYHQWSURWHLQDQGIDWGH¿FLW Prediction ,QKRXUVDWSRVWDFXWHDQG
rehabilitation phase
Micronutrien 3UHYHQWPLFURQXWULHQWGH¿FLHQFXDQG
optimize macronutrien metabolism
Monitoring sheet Daily 
Glycemia Prevent overfeeding and hypoglycemia Laboratory examination In acute phase: several times
In post acute phase: daily
Insulin dosage Prevent overfeeding and hypoglycemia Dynamic algoritm of therapy In acute phase: several times
In post acute phase: daily
Electrolyte, ureum, 
creatinine, liver function
Prevent refeeding syndrome Laboratory examination At the beginning. If abnormal, evaluate 
daily. If normal, evaluate 2-3 times/
week
Albumin Know nutritional status while 
LQÀDPPDWLRQQRWSUHVHQW
Laboratory examination Post acute: weekly
Not recommended in cute phase 
EHFDXVHRILQÀDPPDWLRQSUHVHQW
Body weight, BMI Nutritional status evaluation Body weight instrument In post acute and rehabilitation 
phase. Not in acute phase because of 
hidration variety
Free fat mass, intra and 
H[WUDFHOOXODUÀXLG
Nutritional status Bioimpedance analysis Postacute and rehabilitation phase 
ZKHQQRÀXLGUHWHQWLRQ
Muscle strenght Evaluate muscle strenght Dynamometer Rehabilitation phase (post ICU)
BMI: body mass index; ICU: intensive care unit
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy48
Luh Putu Listya Paramita, Ari Fahrial Syam
10. Maxim S. Petrov and John A. Windsor. Nutritional management 
of acute pankreatitis: the
11. concept of ‘gut rousing’. Curr Opin Clin Nutr Metab 
Care.2013;16:557–63.
12. Kumar A, Singh N, Prakash S.. Early enteral nutrition in severe 
acute pankreatitis: a prospective randomized controlled trial 
comparing nasojejunal and nasogastric routes. Journal of 
Clinical Gastroenterology 2006;40:431-4.
13. Olah A, Romics L. Enteral nutrition in acute pancreatitis: 
a review of the current evidence. World J Gastroenterol 
2014;20:16123-31.
14. Yu-sui Chang, Hua-qun Fu, Yuan-mei Xiao. Nasogastric or 
nasojejunal feeding in predicted severe acute pancreatitis: a 
meta-analysis. Critical Care 2013;17:2-9.
15. Gianotti L, Meier R, Lobo DN. ESPEN guideline on parenteral 
nutrition: pancreas. Clinical Nutrition 2009;28:428-35.
16. Besselink MG, Van SH, Buskens E. Probiotic prophylaxis in 
predicted severe acute pankreatitis: a randomised, double-
blind, placebo-controlled trial. Lancet 2008;371:651-9. 
17. Thibault R, Heidegger C, Bergerc. Parenteral nutrition in the 
intensive care unit: cautious use improves outcome. Swiss 
Medical Weekly 2014;144:13997.
18. Nguyen N. Pharmacological therapy of feed intolerance in 
the critically ills. World J Gastrointestinal Pharmacol Ther 
2014;5:148-55.
